absci.com (ABSI) - Dhuwit awis perusahaan

Logo grafis Absci Corp (ABSI)

Absci is developing a scalable AI drug generation laboratory, monetizing licenses for pharmaceutical behemoths. The business relies on proprietary algorithms, delegating wet-lab testing to external CROs. Explosive growth in B2B contracts and royalties ensures the ecosystem's stability. The company's cash resource dynamics demonstrate its liquidity level, while 0.17 captures the current state of the free capital parameter.

Dhuwit awis perusahaan: Absci Corp (ABSI) kanggo 04.07.2022 - 21.11.2026

Absci Corporation (ABSI) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Analisis komprehensif perusahaan:Absci
Produk merek absci.com

Investors assess fundamental capital risks by analyzing an issuer's ability to cover operating expenses without external borrowing. For Absci (ABSI), which is developing a B2B AI antibody generation ecosystem with a growing contract pipeline, financial autonomy is critical. The company's cash liquidity reflects its current cash reserves, allowing for a comparison of real business resilience against industry standards. Growth in this reserve confirms the safety of expansion, although excess funds may temporarily limit the overall return on invested capital.

Perusahaan pesaing

Volume dana dhuwit perusahaan VEEV|Doximity, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|HealthEquity - Dhuwit awis perusahaan|Aset likuid perusahaan Waystar Health (WAY)|CRVL - Dana dhuwit perusahaan|Sisa dhuwit perusahaan PRVA (Privia Health Group)|HURN: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan certara.com (CERT)|Dana dhuwit perusahaan Omnicell Inc|GoodRx Corp (GDRX) - Aset likuid perusahaan|Dhuwit awis perusahaan SDGR (Schrodinger Corp)|Aset likuid perusahaan Phreesia, Inc.|Dana dhuwit perusahaan Omada Health, Inc. OMDA|EVH - Dhuwit awis perusahaan|HealthStream - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan DH (Definitive Healthcare Corp.)|Consensus (CCSI) - Dana dhuwit perusahaan|Dhuwit awis perusahaan agilon health Inc|Dana dhuwit perusahaan So-Young International|National Research Corp. (NRC) - Aset likuid perusahaan|Dana dhuwit perusahaan USA Mobility (SPOK)|OPRX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan TruBridge Corp TBRG|Simulations Plus Inc. - Dana dhuwit perusahaan|Sophia Genetics - Volume dana dhuwit perusahaan|HCAT - Volume dana dhuwit perusahaan|CCLD: Volume dana dhuwit perusahaan|RSSS: Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan DLHC|Dhuwit awis lan setara dhuwit awis perusahaan ONMD (OneMedNet Corporation)|Dhuwit awis perusahaan SCNX (Scienture)|HCTI (healthcaretriangle.com) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan iSpecimen Inc ISPC|Sisa dhuwit perusahaan BFRG|WORX: Dhuwit awis perusahaan|Aset likuid perusahaan MSP Recovery Corp MSPR|ICCT: Volume dana dhuwit perusahaan|MEDS: Gunggung dana dhuwit perusahaan|ORGS (Orgenesis Corporation) - Volume dana dhuwit perusahaan|RCM: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SHCR|Dhuwit awis perusahaan Streamline Health Solutions Inc. STRM|Syra Health Corp. - Dhuwit awis perusahaan|ApolloMed (AMEH) - Cadangan dhuwit perusahaan|Model N Inc - Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan NextGen Healthcare, Inc. (NXGN)